Optinose Reports Growth in Q1 and Optimistic Outlook for XHANCE
YARDLEY, PA — Optinose (NASDAQ: OPTN), a specialty pharmaceutical company, announced its financial results for the first quarter of 2024, showcasing a strong performance with a notable increase in revenue …
Optinose Reports Growth in Q1 and Optimistic Outlook for XHANCE Read More